DRMA Earnings Dermata Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–10 of 10
| Q1 2026 | 2026-03-31 | -0.48 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -8.16 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | -6.64 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -5.18 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -4.47 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -80.32 | 2026-03-26 | 10-K |
| Q3 2025 | 2024-09-30 | -102.18 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -106.44 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | -7.06 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -39.99 | 2025-03-17 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.